FPH enters into construction contract for fifth NZ building

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare enters into construction contract for fifth building in New Zealand

Auckland, New Zealand, 6 March 2025 – Fisher & Paykel Healthcare Corporation Limited announced today that it has signed a building construction contract with Dominion Constructors Limited for the fifth building on its East Tāmaki campus in Auckland.

"We are excited to add this new building to complete our East Tāmaki campus," said Andy Niccol, Chief Operating Officer. “This project is a purposeful investment in infrastructure to ensure we have the necessary capacity and resources in New Zealand to progress our pipeline of innovative products and therapies.”

With a total gross floor area of about 28,000m2, the new building will showcase a cohesive blend of spaces for research and development, manufacturing and distribution. The building’s design will reflect the company’s culture of collaboration, with an open-plan work environment. The estimated total cost of the new building is expected to be approximately NZ$250 million.

The 42-hectare East Tāmaki site currently has over 3,900 employees, and the new building will accommodate the company’s expected growth in Auckland over the next five years. Earthworks have been largely completed and construction will start later this month, with the facility expected to be operational in 2027.

The company also recently submitted a private plan change application for its additional New Zealand campus at Karaka, Auckland, to accommodate growth over the longer term.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

Contacts:
Media
Karen Knott
GM Corporate Communications
[email protected]
+64 (0) 21 713 911

Investors:
Dan Adolph
Head of Investor Relations
[email protected]
+64 (0) 22 511 4050

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board of Directors.

---

Announcement PDF